Share of Men's Prescription Fills for Weight-Loss Medications by Age

Click on the buttons below to view the data for different on-label indications for GIP and GLP-1 agonists.
WEIGHT LOSS TYPE 2 DIABETES

(Please use a modern browser to see the interactive version of this visualization)

Data reflect retail prescription fills from January 1, 2022, through June 15, 2026. Medications were grouped by FDA-approved, on-label indication. Weight-loss medications include Zepbound, Wegovy, Foundayo, Saxenda, and liraglutide (Saxenda). Type 2 diabetes medications include Ozempic, Mounjaro, Victoza, and liraglutide (Victoza).